Q Advisors Represents Summit Doppler Systems in its Acquisition by CooperSurgical

TRUMBULL, CT, August 25, 2011 - CooperSurgical, Inc. is pleased to announce the acquisition of Summit Doppler Systems, Inc. Summit, based in Golden, Colorado, is a recognized leader and quality manufacturer of hand-held ultrasound Doppler products used to detect fetal heart beat and monitor blood flow. Prior to the acquisition, CooperSurgical was a Summit customer purchasing their reliable obstetrical ClearTone® Doppler for many years.

Summit is also known for its advanced solutions for the diagnosis of Peripheral Arterial Disease (PAD). This is a common condition that affects 8-12 million people in the US, and early detection can prevent patients from further cardiovascular events. As a result, there is a growing awareness of PAD and the importance of its diagnosis and treatment.

Summit has a strong distributor sales channel as well as international distribution in over 80 countries with a diverse group of end users ranging from general practices and hospitals to specialists such as cardiologists, vascular surgeons and obstetricians.

The Summit team of 16 people will remain in Golden, Colorado; CooperSurgical will leverage its extensive engineering knowledge and market expertise with CooperSurgical’s broad capabilities and reach.

About CooperSurgical

CooperSurgical is the leading company dedicated to providing medical devices and procedure solutions that improve health care delivery to women regardless of clinical setting. The company is fostering that position through expansion of its core businesses and introduction of advanced, technology-based products that aid clinicians in the management and treatment of commonly seen conditions.

The company is committed to continued expansion of its core business through internal development programs and acquisition strategies. Since its inception in 1990, CooperSurgical has steadily grown its market presence and distribution system by developing and purchasing products and acquiring companies that complement its business focus. The company now has an established customer base serving well over 65% of women's health care providers, with sales approaching $200 million.